Jardine Matheson's I-MED Acquisition Could Boost Target's Growth -- Market Talk

Dow Jones05-28

0317 GMT - Jardine Matheson's US$2.4 billion buy of I-MED Radiology Network is likely to boost the latter's growth potential, says S&P Global Ratings in a report. Jardine seems willing to spend on expansion and explore new markets, which should be beneficial for I-MED. S&P expects I-MED to realize 10%-15% annual Ebitda growth within the Hong Kong-based conglomerate's portfolio, which is in line with I-MED's 12% reported Ebitda growth for five years up to end-June last year. Growth drivers include organic growth in Australia and New Zealand's medical-imaging market and network expansion in these markets. Meanwhile, S&P expects Jardine to keep exploring potential deals, as it retains the ability to sell assets to fund acquisitions. Its Singapore-listed shares fall 4.0% to US$65.28. (megan.cheah@wsj.com)

(END) Dow Jones Newswires

May 27, 2026 23:17 ET (03:17 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2638659837?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 11:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2638659837","market":"other","top_or_hot":-1,"title":"Jardine Matheson's I-MED Acquisition Could Boost Target's Growth -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0317 GMT - <a href=\"https://laohu8.com/S/JARLF\">Jardine Matheson</a>'s US$2.4 billion buy of I-MED Radiology Network is likely to boost the latter's growth potential, says S&amp;P Global Ratings in a report. Jardine seems willing to spend on expansion and explore new markets, which should be beneficial for I-MED. S&amp;P expects I-MED to realize 10%-15% annual Ebitda growth within the Hong Kong-based conglomerate's portfolio, which is in line with I-MED's 12% reported Ebitda growth for five years up to end-June last year. Growth drivers include organic growth in <a href=\"https://laohu8.com/S/AN3PF.AU\">Australia and New Zealand</a>'s medical-imaging market and network expansion in these markets. Meanwhile, S&amp;P expects Jardine to keep exploring potential deals, as it retains the ability to sell assets to fund acquisitions. Its Singapore-listed shares fall 4.0% to US$65.28. (megan.cheah@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 27, 2026 23:17 ET (03:17 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jardine Matheson's I-MED Acquisition Could Boost Target's Growth -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJardine Matheson's I-MED Acquisition Could Boost Target's Growth -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-28 11:17</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0317 GMT - <a href=\"https://laohu8.com/S/JARLF\">Jardine Matheson</a>'s US$2.4 billion buy of I-MED Radiology Network is likely to boost the latter's growth potential, says S&amp;P Global Ratings in a report. Jardine seems willing to spend on expansion and explore new markets, which should be beneficial for I-MED. S&amp;P expects I-MED to realize 10%-15% annual Ebitda growth within the Hong Kong-based conglomerate's portfolio, which is in line with I-MED's 12% reported Ebitda growth for five years up to end-June last year. Growth drivers include organic growth in <a href=\"https://laohu8.com/S/AN3PF.AU\">Australia and New Zealand</a>'s medical-imaging market and network expansion in these markets. Meanwhile, S&amp;P expects Jardine to keep exploring potential deals, as it retains the ability to sell assets to fund acquisitions. Its Singapore-listed shares fall 4.0% to US$65.28. (megan.cheah@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 27, 2026 23:17 ET (03:17 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4532","symbol_name":"文艺复兴科技持仓","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2638659837","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2638659837","pubTimestamp":1779938220,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0317 GMT - Jardine Matheson's US$2.4 billion buy of I-MED Radiology Network is likely to boost the latter's growth potential, says S&P Global Ratings in a report. Jardine seems willing to spend on expansion and explore new markets, which should be beneficial for I-MED. S&P expects I-MED to realize 10%-15% annual Ebitda growth within the Hong Kong-based conglomerate's portfolio, which is in line with I-MED's 12% reported Ebitda growth for five years up to end-June last year. Growth drivers include organic growth in Australia and New Zealand's medical-imaging market and network expansion in these markets. Meanwhile, S&P expects Jardine to keep exploring potential deals, as it retains the ability to sell assets to fund acquisitions. Its Singapore-listed shares fall 4.0% to US$65.28. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4532":"文艺复兴科技持仓","SG9999003826.SGD":"日兴资管新加坡股息基金 SGD","SG9999000475.SGD":"Aberdeen Standard Singapore Equity SGD","IE0031814969.USD":"FSSA ASEAN ALL CAP FUND \"I\" (USD) ACC","SG9999000343.SGD":"Schroder Singapore Trust A Dis SGD","SG9999006266.SGD":"MANULIFE SINGAPORE EQUITY \"A\" (SGD) ACC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","JMHLY":"怡和洋行","J36.SI":"怡和控股有限公司","BK4206":"工业集团企业","SG9999016042.SGD":"Schroder Singapore Trust A Acc SGD","BK4183":"个人用品","LU1150488218.USD":"First Eagle Amundi Income Builder AU2-MD USD","LU0469268626.HKD":"AB FCP I-ASIA EX JAPAN EQUITY PTF(AD","BK6111":"工业集团企业","MED":"快验保","IE0008369823.USD":"FSSA HONG KONG GROWTH \"I\" ACC","SG9999004360.SGD":"Nikko AM Shenton Thrift Fund SGD","LU1150488135.SGD":"First Eagle Amundi Income Builder AHS-MD SGD-H","BK6505":"周期性消费品与消费者服务"},"translate_title":"怡和集团收购I-MED可能会促进塔吉特的增长——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MED":1.5,"JMHLY":0.9,"J36.SI":1.5},"content_text":"0317 GMT - Jardine Matheson's US$2.4 billion buy of I-MED Radiology Network is likely to boost the latter's growth potential, says S&P Global Ratings in a report. Jardine seems willing to spend on expansion and explore new markets, which should be beneficial for I-MED. S&P expects I-MED to realize 10%-15% annual Ebitda growth within the Hong Kong-based conglomerate's portfolio, which is in line with I-MED's 12% reported Ebitda growth for five years up to end-June last year. Growth drivers include organic growth in Australia and New Zealand's medical-imaging market and network expansion in these markets. Meanwhile, S&P expects Jardine to keep exploring potential deals, as it retains the ability to sell assets to fund acquisitions. Its Singapore-listed shares fall 4.0% to US$65.28. (megan.cheah@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2026 23:17 ET (03:17 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2638659837","isCrawlerRequest":true}